(PRWEB) December 23, 2013
According to a new technical market research report, In Vitro Toxicity Testing: Technologies and Global Markets, from BCC Research (http://www.bccresearch.com), the global in vitro toxicity testing market was valued at more than $4.9 billion in 2012. BCC Research projects the market to grow to nearly $9.9 billion by 2017, and register a five-year compound annual growth rate of 14.7% from 2012 to 2017.
Toxicology, the study of the adverse effects of chemical, physical or biological agents on living organisms and the ecosystem, is based on the principle that any substance can be toxic if consumed in sufficient quantity. Most developed countries have laws and regulations to control the marketing of drugs, vaccines, food additives, pesticides, industrial chemicals and other substances of potential toxicological concern. Such regulations often prescribe a specific regime of toxicity testing to generate information that will enable government regulators to determine whether the benefits of a particular substance outweigh its risks to human health and/or the environment.
Classical toxicology testing programs have been in place for many decades now. These tests are designed to generate definitive data concerning the adverse effects of a substance on human or animal health or the environment. Many toxicity tests examine specific types of adverse effects, known as end points, such as eye irritation or cancer. Over the past 20 years, animal welfare and scientific activities have spurred the development of alternative testing methods. Ongoing research, development and scale-up of in vitro and in silico methods include an array of advanced technology platforms that are gaining traction commercially.
This technical market research report from BCC Research provides a comprehensive overview of the major types of traditional toxicity testing in use, and the in vitro techniques that are being developed by industry, government agencies, and nonprofits. It also details the recent key technical advances in different toxicology categories, and the extent of adoption by commercial customers and regulatory authorities. In addition, this study analyzes current market status, examines drivers of future markets and presents forecasts of growth over a five year period. Technology developments, including the latest trends, are also discussed. Other influential factors such as validation and testing strategies for pharmaceuticals, cosmetics, and chemicals have been included as well.
Regulatory measures play an important role in toxicology because they determine the specific parameters of tests that are required. Consequently, they also heavily influence the testing that is performed by companies in earlier stages of research. This report examines the current regulations and the different federal and international agencies that play an active role in in vitro toxicology research, development, and adoption.
This report is designed to satisfy the information needs of a wide variety of individuals involved in toxicology, in vitro and in silico marketplaces, including company senior management executives seeking to base their strategic decisions on the latest insights into toxicology market forces and trends. It is also aimed at managers and executives in product research and development and particularly those responsible for bringing new products to market.